Company: AVNT
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001122976-25-000088
Chunk: 3

Company: AVIENT CORP
Filing Date: 2025-11-05
Form: 10-Q
Item: Part I, Item 2
Chunk 3
---
 294.6       3.1                             1.1      935.8                  18.7                            2.0  
  Corporate                           (1.1)                   (0.9)       (0.2)                            nm      (4.4)                  (2.4)                            nm  
  Total sales                         $                       $           $                             (1.1)      $                      $                               0.2  
  Operating income:                                                                                                                                                            
  Color, Additives and Inks           $                       $           $                             (2.3)      $                      $                               2.7  
  Specialty Engineered Materials      37.3                    36.4        0.9                             2.5      124.6                  (8.0)                         (6.0)  
  Corporate                           (44.0)                  (34.7)      (9.3)                        (26.8)      (203.4)                (78.1)                       (62.3)  
  Total operating income              $                       $           $                            (13.1)      $                      $                            (32.7)  

Color, Additives and Inks

Sales decreased $11.6 million, or 2.2%, in the three months ended September 30, 2025 compared to the three months ended September 30, 2024. Favorable foreign currency impacts were 2.0%, while sales, excluding the impacts of foreign exchange, decreased 4.2%. The sales decrease was primarily within the consumer, packaging and building and construction end markets, partially offset by a sales increase in the healthcare end market.

Sales decreased $10.6 million, or 0.7%, in the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024. Favorable foreign currency impacts were 0.4%, while sales, excluding the impacts of foreign exchange, decreased 1.1%. The sales decrease was primarily within the consumer, transportation and building and construction end markets, partially offset by a sales increase in the healthcare end market.

Operating income decreased $1.7 million for the three months ended September 30, 2025 compared to the three months ended September 30, 2024. The decrease was primarily driven by lower sales, partially offset by cost savings from productivity and restructuring actions and lower incentive compensation.

Operating income increased $6.3 million for the nine